9688 — Zai Lab Income Statement
0.000.00%
Last trade - 00:00
- HK$10.69bn
- HK$4.38bn
- $266.72m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 13 | 49 | 144 | 215 | 267 |
Cost of Revenue | |||||
Gross Profit | 9.24 | 32.2 | 92.1 | 141 | 171 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 216 | 351 | 844 | 619 | 633 |
Operating Profit | -203 | -302 | -700 | -404 | -367 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -194 | -268 | -703 | -443 | -335 |
Provision for Income Taxes | |||||
Net Income After Taxes | -194 | -268 | -703 | -443 | -335 |
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -195 | -269 | -704 | -443 | -335 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -195 | -269 | -704 | -443 | -335 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.303 | -0.346 | -0.758 | -0.463 | -0.357 |